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Background: LINE-1 (long interspersed element-1) or L1-mediated retrotransposition is a potent force in human genome evolution and an
occasional cause of human genetic disease. Since the first report of two de novo L1 insertions in the F8 gene causing hemophilia A, more
than 50 L1-mediated retrotranspositional events have been identified as causing human genetic disease. However, a significant bias has
generally militated against the detection of these pathological events at autosomal loci. Based upon this and other observations, we surmised
that some previously unresolved cystic fibrosis chromosomes might carry hitherto undetected L1-mediated retrotranspositional insertions at
the CFTR locus. This study represents an attempt to identify such mutational events.
Methods: 100 previously unresolved cystic fibrosis chromosomes were carefully reanalyzed using quantitative high-performance liquid
chromatography (QHPLC).
Results: Two simple Alu insertions were identified in the CFTR gene, within exons 16 and 17b respectively.
Conclusions: Our findings have not only revealed a previously unknown mutational mechanism responsible for cystic fibrosis but also
represent an important addition to the already diverse spectrum of known CFTR gene mutations. Experience with the CFTR gene suggests
that pathological L1-mediated retrotranspositional events may also have been overlooked at other gene loci and should always be considered
in cases that appear to be refractory to analysis.
© 2007 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Alu sequence; Cystic fibrosis; Gross insertion; L1; LINE-1; Retrotransposition1. Introduction
LINE-1 (long interspersed element-1) or L1-mediated
retrotransposition has driven human genome evolution in a
variety of different ways [1] but has also caused human⁎ Corresponding author. INSERMU613, Etablissement Français du Sang-
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1569-1993/$ - see front matter © 2007 European Cystic Fibrosis Society. Publish
doi:10.1016/j.jcf.2007.04.001genetic disease [2]. Since the first report of two de novo L1
insertions in the factor VIII gene (F8; MIM #306700)
causing hemophilia A [3], more than 40 L1-mediated simple
retrotranspositional events (i.e. those involving no loss of
genetic material from the target site) including L1 direct, L1
trans-driven Alu and L1 trans-driven SVA (short inter-
spersed elements-R, variable number of tandem repeats, and
Alu insertions) insertions have been identified as causing
human genetic disease [2,4]. In addition, L1 retrotransposi-
tion has also been shown to be directly linked to theed by Elsevier B.V. All rights reserved.
Table 1
Characteristics, possible functional consequences, and mutations in trans, of the two simple Alu insertions in the CFTR gene
Alu
insertion
Integration
site
Sub-family,
Alu inserta
Total length
of insertion
Length of Alu
sequence/5′ truncation
Length of
poly(A) tail
Orientation
of insertionb
Size of target
site duplication
Presumed functional
consequence of insertionc
Mutation
in trans
#1 Exon 16 Y 103 bp 46 bp/yes 57 bp Antisense 18 bp Aberrant splicing p.
F508del
#2 Exon 17b Ya5 337 bp 281 bp/no 56 bp Sense 19 bp Aberrant splicing p.E92X
aWhereas the sub-family of #2 was annotated by RepeatMasker (http://www.repeatmasker.org/cgi-bin/WEBRepeatMasker), that of #1 was annotated manually
against an alignment of AluSq, AluY, AluYa5, AluYb8 and AluYb9 consensus sequences.
bWith respect to the sense strand of the CFTR gene.
cBy analogy to known examples of pathological simple Alu inserts that are informative with respect to the functional disruption of their target genes at the RNA
level [4].
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target gene sequences [2,4]. It should be noted that a sig-
nificant bias has militated against the detection of patho-
logical L1 direct or trans-driven insertions in the autosomes
[4].
The cystic fibrosis transmembrane conductance regulator
gene (CFTR; MIM #602421), located on chromosome
7q31.2, is one of the most extensively studied human dis-
ease genes. Of the 1523 different lesions currently listed in
the Cystic Fibrosis Mutation Database (http://www.genet.
sickkids.on.ca/cftr/app; as of December 6, 2006), N97% are
either single base-pair substitutions or microinsertions/dele-
tions. Recently, however, an increasing number of large geno-
mic rearrangements have been reported in the CFTR gene, a
development potentiated by the introduction of quantitative
PCR-based techniques [5–15]. Of the ∼30 such mutational
events already documented in the literature, 21 have been
fully characterized at the nucleotide level [10]. Until now,
however, only two non-deletion-containing gross genomic
rearrangements have been reported in theCFTR gene: a 31 bp
complex duplicational insertion in exon 20 [16] and an
incompletely characterized (i.e. breakpoints not determined)
duplication of exons 4–8 [6].
On the basis of four lines of observation viz. (i) the abun-
dance of both L1 elements and Alu sequences in the human
genome [17], (ii) the essentially random integration of L1
retrotransposons into the human genome [18,19], (iii) the
significant bias against detection of pathological L1-mediatedFig. 1. Identification of the #1 simple Alu insertion in the CFTR gene. (a) Employ
significantly reduced in a 24-year-old French girl with typical cystic fibrosis (in r
amplify exon 16]. (b) QHPLC analysis of exon 16 of the CFTR gene in the patient a
of an additional small peak (downward pointing arrow) in the patient and her father.
for the QMPSF analysis) products from the patient and her relatives run on a 2% ag
and her father. (d, e) Wild-type and mutant genomic sequences of exon 16 (in upper
5′ to 3′ orientation with respect to the sense strand of the CFTR gene. Shaded s
Underlined sequences denote the primer pair used for the QHPLC analysis (this s
LINE-1 endonuclease-dependent retrotranspositional events, is highlighted in bold.
tail that has been inserted in the antisense orientation with respect to the transcriptio
was deleted (e), probably by replication slippage. (f) Deduced top and bottom stra
Note that although this figure was derived from d and e, the top strand represents
cleavage sites are indicated by arrows. Shaded sequences on the bottom strand indic
site, 3′-A/TTTT-5′.retrotransposons in the autosomes [4], and (iv) the fairly large
size of the CFTR gene [20,21], we surmised that some pre-
viously unresolved cystic fibrosis chromosomes might carry
hitherto undetected L1-mediated retrotranspositional inser-
tions at the CFTR locus.
This study therefore represented an attempt to identify
such mutational events by carefully reanalyzing a total of
100 such chromosomes using quantitative high-performance
liquid chromatography (QHPLC). This technique has been
previously employed to delineate the boundaries of large
genomic deletions in the CFTR gene [5,10], to identify a
large genomic deletion in the SPINK1 gene (MIM #167790)
[22] and to detect a triplication of the trypsinogen locus on
chromosome 7q [23]. Using QHPLC, two simple Alu in-
sertions were identified within the CFTR gene.
2. Materials and methods
Some 100 cystic fibrosis chromosomes that had remained
unresolved after our previous studies [5,10] were screened for
insertions in all 27 exons of the CFTR gene (with the excep-
tion of exon 1; see Results and discussion section) by means
of QHPLC [5,22,23]. The PCR primers used were those listed
in Table 1 of Ref. [24]. DNA quantification was performed
using the Quant-iT™ PicoGreen® dsDNA reagent (Invitro-
gen, Eugene, Oregon, USA). PCRwas usually performed in a
50-μl reaction mixture containing 200 μM each dNTP, 1–
2.5 mM MgCl2, 1 U AmpliTaq DNA polymerase (PEing QMPSF [5], the peak height of the exon 16 amplicon was found to be
ed) as compared with a normal control (in blue). [See d for primers used to
nd her relatives. Note the reduced height of the main peak and the appearance
(c) Electrophoretic profiles of PCR (performed under the same conditions as
arose gel. Note the appearance of a longer (albeit weaker) band in the patient
case) and its flanking sequence in the CFTR gene. Sequences are given in the
equences correspond to the primer pair used for the QMPSF analysis [5].
tudy). The target site duplication (TSD), a characteristic hallmark of simple
Sequence in italics (e) indicates the 46 bp Alu element plus the 57 bp poly(A)
nal direction of the target gene. The second t (barred) of the downstream TSD
nd cleavage sites involved in the #1 simple Alu insertion in the CFTR gene.
the antisense strand of the CFTR gene. The TSD is shown in bold and the
ate nucleotides matching the degenerate L1 endonuclease consensus cleavage
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and 50 ng genomic DNA. The PCR program comprised an
initial denaturation step at 94 °C for 3 min, followed by 20–24 cycles of denaturation at 94 °C for 30 s, annealing at 50–
57 °C for 30 s, and extension at 72 °C for 30–90 s. Each exon
was analyzed individually. Samples that exhibited an
40 J.-M. Chen et al. / Journal of Cystic Fibrosis 7 (2008) 37–43apparent reduction in the peak height of a given amplicon
upon QHPLC (as compared with other simultaneously an-
alyzed samples) were subjected to a second PCR ampli-
fication of 40 cycles, with or without a prolonged elongation
time. A fraction of the resulting product was examined on an
agarose gel for the presence of a larger but weaker band.
Whenever such a band was detected, the remaining PCR
products were cloned into the pGEM®-T Easy Vector System
(Promega Corporation, Madison, WI); JM109 competent
cells were transformed and PCR colony minipreps used to
screen plasmids containing inserts of interest; such plasmids
were prepared and sequenced using the ABI PRISM™
BigDye™ Terminator Cycle Sequencing Kit (PE Applied
Biosystems, Foster City, CA). The nature of the identified
insertions was determined by annotation with RepeatMasker
(http://www.repeatmasker.org/cgi-bin/WEBRepeatMasker)
as well as by reference to the characteristic hallmarks of L1-
endonuclease-dependent retrotransposition [2].
3. Results and discussion
Unlike the L1 direct insertions and L1 trans-driven SVA
insertions, all the disease-causing L1 trans-driven Alu in-
sertions have a length of b400 bp including their poly(A) tails
[2]. Such lesions are therefore potentially identifiable by
conventional PCR-based methods. However, in practice, sim-
ple Alu insertional events, particularly those occurring on the
autosomes, can easily be overlooked as a consequence of a
number of different factors e.g. the elongation time of the PCR
cycle, the migration time of PCR products in the agarose gel, a
masking effect of fragments derived from the preferentially
amplified shorter wild-type allele etc. Indeed, one of our recent
meta-analytical studies indicated that, of 15 simple autosomal
Alu insertions informative with respect to the methods that
initially suggested/identified the mutation at the nucleotide
level,∼1/3 were attributable to Southern blotting, RT-PCR or
protein truncation [4]. An appreciation of the bias inherent in
the detection of autosomal L1-mediated retrotranspositional
events prompted us to re-analyze a collection of some 100
previously unresolved cystic fibrosis chromosomes.
3.1. Identification of a hitherto undetected Alu insertion in
the CFTR gene
In a 24-year-old French girl with one unresolved CFTR
allele, QMPSF analysis [5] had originally demonstrated a
two-fold reduction in the peak height of the exon 16
amplicon (Fig. 1a). At this time, we had been perplexed by
our failure to identify an expected large genomic deletion
despite repeated efforts. Although an altered elution pattern
of the exon 16 amplicon in this patient had previously been
observed by denaturing gradient gel electrophoresis [25],
direct sequencing of the corresponding PCR products re-
vealed only what appeared to be a wild-type sequence (un-
published data). With hindsight, this is likely to have been
due to masking by the preferentially amplified shorter non-insertional allele of normal length. [The non-insertional
allele in each of the two patients under study here carries a
known pathological mutation in the CFTR gene (Table 1).]
Meta-analyses of known L1-mediated retrotranspositional
events causing human genetic disease [2,4] alerted us to the
potential presence of an intragenic insertion rather than a
deletion in this particular case. To test this possibility, we
first sought to establish whether the QMPSF findings could
be replicated using a second quantitative PCR-based tech-
nique. Thus, exon 16 of the CFTR gene was analyzed by
QHPLC; DNAwas PCR amplified from the patient and her
relatives, employing the same cycling program (extension
time, 30 s) used for QMPSF analysis but utilizing a different
primer pair (see Fig. 1d for comparison). As shown in
Fig. 1b, the peak height of the exon 16 amplicon was signi-
ficantly lower in both the patient and her father as compared
with her mother and brother. More importantly, an additional
small peak also appeared in the patient and her father (in-
dicated in Fig. 1b by the downward pointing arrow). That the
additional peak appeared later than the main peak was
indicative of the potential presence of an insertional allele in
trans to the non-insertional allele of normal length.
PCR amplification of exon 16 was then performed inde-
pendently under the same conditions as for the QMPSF
analysis; the resulting PCR products were evaluated on an
agarose gel. As shown in Fig. 1c, in addition to a band of
157 bp, a second weaker band of∼300 bp was present in both
the patient and her father. Cloning and sequencing of the larger
band resulted in the identification of the first simple Alu
insertion to be reported in theCFTR gene (termed #1). The key
features of this insertion are illustrated in Fig. 1e and sum-
marized in Table 1. Here we would simply like to make four
points: (i) the bottom strand or first cleavage site, 3′-A/TTCT-
5′ (Fig. 1f), matches the L1 endonuclease degenerate
consensus target sequence (3′-A/TTTT-5′ and variants
thereof) [26–30], (ii) a thymine base within the downstream
target site duplication (TSD) was deleted (Fig. 1e), an
observation which can in principle be accounted for by the
canonical model of replication slippage [31], (iii) the
paternally inherited Alu insertion (Fig. 1c) is likely to cause
aberrant splicing of the CFTR gene, by analogy to the
pathological simple Alu insertions that are informative with
respect to their functional consequences at the RNA level [4],
and (iv) the #1 Alu insertion in CFTR constitutes the shortest
of the currently reported pathological simple Alu insertions.
3.2. A systematic analysis of the CFTR gene by QHPLC
resulted in the identification of a second simple Alu insertion
The #1 Alu insertion occurred within the short region
spanned by the QMPSF primer pair targeting exon 16 (see
Fig. 1d, e). Thus, the #1 insertion would not have been
detected by QMPSF analysis had it occurred outside this
short region. In this regard, inspection of the locations of the
primer pairs used for the QMPSF analysis [5] revealed that
∼50% of the CFTR coding sequence was located outside the
41J.-M. Chen et al. / Journal of Cystic Fibrosis 7 (2008) 37–43targeted regions (Fig. 2). [Note that with respect to QMPSF,
the primer selection was limited by the requirement to
simultaneously amplify multiple short fragments in a single
PCR reaction.] Clearly, while QMPSF represents a powerful
tool for detecting large genomic deletions, it is inadequate to
the task of detecting gross insertions.
Becoming aware of the limitations of QMPSF for detecting
gross insertions prompted us to perform a systematic screen of
the entire coding sequence of the CFTR gene by QHPLC for
all hitherto unresolved cystic fibrosis chromosomes. Primer
pairs previously designed for the rapid and complete screening
of the CFTR gene by denaturing high-performance liquid
chromatography [24] were employed. The rationale was that if
a large insertion could not be amplified under a given PCR
program, it would appear as if it were a large deletion in the
QHPLC analysis. Alternatively, if a large insertion could be
amplified albeit at a lower efficiency, it would manifest in the
same way as in the case of the #1 Alu insertion in the CFTR
gene (see Fig. 1b). However, the heights of the two peaks of
interest are likely to be reciprocally proportional to each other,
depending upon the relative amplification efficiency of the
insertional allele as compared with the non-insertional allele.
Since the coding sequence of exon 1 had already been
screened by QMPSF (see Fig. 2), only the remaining 26 exons
of the CFTR gene were analyzed here. In a 28-year-old Czech
man with typical cystic fibrosis, QHPLC analysis consistently
revealed an exon 17b amplicon with reduced peak height
followed by a smaller peak as compared with a normal control
(Fig. 3a). That the main peak was modestly reduced concurs
with the presence of a very small peak in the patient (see the
relative heights of the two peaks in the patient in Fig. 1b for
comparison); this was consistent with the presence of an
insertional allele that was amplified with very low efficiency
when a PCR extension time of 45 s was employed. In order to
improve recovery of this putative insertional allele, the
extension time was increased to 90 s. A strong band of
∼750 bp in both the patient and his mother then became
evident (Fig. 3b). Subsequent cloning and sequencing of this
band confirmed a second simple Alu insertion in exon 17b of
theCFTR gene (termed #2) that had, not surprisingly, occurred
outside the short QMPSF-targeted region (Fig. 3c, d).Fig. 2. Schematic illustration of the locations of the primer pairs employed
(indicated by pairs of arrows) with respect to their target exons (indicated by
boxes) in QMPSF [5] and QHPLC (this study), respectively.The key features of this #2 Alu insertion are summarized
in Table 1. However, two points are worthy of further
attention. Firstly, an additional much weaker band of size
approaching 700 bp was apparent in the patient and his
mother (Fig. 3b). Since no such insert was identifiable by
PCR colony miniprep, its nature remains undetermined.
However, this band, which was absent in the father, migrated
midway between the insertional and normally sized bands
suggesting that it could represent a heteroduplex formed
between the insertional and normally sized alleles. Secondly,
the deduced bottom strand cleavage sequence of the #2
insertion is 3′-C/TTAT-5′ (Fig. 3e). This is the second ex-
ample, from the more than 50 L1-mediated retrotransposi-
tional events currently known to cause human genetic
disease, where a cytosine has been found to be present 3′ to
the bottom strand cleavage site. The first example, 3′-C/
TTCT-5′, was a de novo Alu insertion detected in the BRCA2
gene (MIM #600185) [32]. Similar cases have been previ-
ously noted in de novo somatic L1 insertions [19,29,30,33]
and may be attributable to ‘relaxed’ L1 endonuclease activity
with a lower degree of specificity, by analogy with the
deduced bottom strand cleavage sequence, 3′-A/CAAA-5′,
in the F8 gene [3].
3.3. The two simple Alu insertions account for ∼0.13% of
known CFTR mutations
The identification of two simple Alu insertions in the
CFTR gene has not only revealed a previously unknown
mutational mechanism responsible for cystic fibrosis but also
represents an important addition to the already diverse
spectrum of CFTR gene mutations. Together they constitute
∼0.13% of the currently reported 1523 different CFTR
mutations (http://www.genet.sickkids.on.ca/cftr/app). This
concurs with earlier estimates that pathological L1-mediated
retrotranspositional events account for 0.1–0.2% of known
disease-associated mutations [4,34].
3.4. Conclusions
Nearly 20 years after the landmark report of Kazazian and
colleagues [3], studies of mutations underlying human
genetic disease still continue to provide fascinating insights
into the nature of L1-mediated retrotransposition. This is
exemplified by the recent identification of a ∼46 kb deletion
in the PDHX gene that was created by the insertion of a full-
length L1 element [35] and the #1 Alu insertion characterized
in the present study. Moreover, characterization of the two
simple Alu insertions within the CFTR gene increased the
number of known human pathological Alu insertions
informative with respect to the starting position of the Alu
insert to 31. A meta-analysis of these pathological events,
when combined with previous findings from in vitro and
genome-wide analyses, has enabled us to propose a unified
model for Alu sequence insertion into the human genome
[36].
Fig. 3. Identification of the #2 simple Alu insertion in the CFTR gene from a Czech man with cystic fibrosis. (a) QHPLC profiles of exon 17b of the CFTR gene.
Note the reduced height of the main peak and the appearance of an additional small peak (downward pointing arrow) in the patient. [See c for the primers used to
amplify exon 17b]. (b) Electrophoretic profiles of PCR (performed with a prolonged extension time as compared with that used for the QHPLC analysis; see text)
products from the patient and his parents on a 2% agarose gel. Note the appearance of a reasonably strong band of∼750 bp in the patient and his mother. See text
regarding the additional band of b700 bp. (c, d) Wild-type and mutant genomic sequences of exon 17b (in upper case) and its flanking sequence in the CFTR
gene. Shaded sequences correspond to the primer pair used for QMPSF analysis [5]. Underlined sequences indicate the primer pair used for the QHPLC analysis.
Sequence in italics (d) identifies the 281 bp Alu insert plus the 56 bp poly(A) tail that has been inserted in a sense orientation with respect to the transcriptional
orientation of the target gene. (e) Deduced top and bottom strand cleavage sites involved in the #2 simple Alu insertion. The target site duplication (TSD) is
shown in bold. Cleavage sites are denoted by arrows. Shaded nucleotides in the bottom strand indicate a highly degenerate L1 endonuclease cleavage site.
42 J.-M. Chen et al. / Journal of Cystic Fibrosis 7 (2008) 37–43It is also worthy of note that nearly 20 years after the
positional cloning of the CFTR gene [20], novel types of
mutation are still being found, for example the recently
found indel containing an ultra short L1 (‘hyphen’) element
[5] and the two novel Alu insertions identified in this study.
Studies of disease-causing CFTR mutations are clearly still
serving to improve our understanding of the basic mechan-
isms underlying mutagenesis in a pathological context, a
conclusion exemplified by the case of the 31 bp complexduplicational insertion in exon 20 of the CFTR gene [16] that
formed the basis of the recently described serial replication
slippage (SRS) model [31,37,38]. It is to be expected that
further studies of mutation in the CFTR gene will continue to
generate novel insights. Finally, experience with the CFTR
gene suggests that pathological L1-mediated retrotransposi-
tional events may also have been overlooked at other gene
loci and should always be considered in cases that appear to
be refractory to analysis.
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